查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401824

學名藥合約製造市場，按材料類型、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Generic Injectable Pharmaceutical Contract Manufacturing Market, By Material Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年學名藥合約製造市場規模為 101 億美元，2023 年至 2030 年複合CAGR為 11.2%。

學名藥合約製造市場-市場動態

醫藥產業製造需求加大醫藥研發投入拉動市場需求

該市場的擴張主要源於製藥業複雜的製造需求、藥品研發投資的增加、對先進技術的日益青睞、專利到期以及冠狀病毒大流行的影響。此外，對細胞和基因療法、個人化藥物的需求不斷成長，以及高效活性藥物成分（HPAPI）和抗體藥物偶聯物（ADC）市場的激增，預計將為市場參與者帶來重大機會。對具有成本效益的學名藥注射藥物的需求持續成長，加上全球醫療保健系統對此類藥物的持續需求，推動了該細分市場的成長。各個利益相關者相互協作，以滿足監管標準，確保生產質量，並滿足醫療保健對可獲取且負擔得起的注射藥物的需求。

學名藥注射藥品合約製造市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 11.2% 左右的CAGR成長

根據材料類型細分，預計大分子將在 2022 年顯示最大的市場佔有率

從應用細分來看，腫瘤學是2022年的主導類型

按地區分類，北美是 2022 年的主要收入來源

學名藥合約製造市場-細分分析：

全球學名藥注射藥品合約製造市場根據材料類型、應用、最終用戶和地區進行細分。

市場依材料類型分為兩類：小分子和大分子。根據材料類型，2022 年的重要收入佔有率由大分子細分市場佔據。對客製化治療和精準醫療的大力關注極大地促進了美國大分子學名藥注射藥物細分市場的成長。此外，包括生物相似藥在內的產品上市的增加也顯著支持了細分市場的擴張。例如，2023年1月，安進在美國推出了修美樂（Humira）的生物學名藥AMJEVITA，這是美國FDA批准的第一個學名藥修美樂（Humira）版本，顯示了預計將促進細分市場成長的因素。

依應用市場分為七類：腫瘤學、免疫學、抗糖尿病。神經病學、心血管病學、呼吸病學等。根據應用情況，腫瘤學領域在 2022 年獲得了最大的收入佔有率。這歸因於擴大推出針對癌症治療的學名藥產品。許多合約製造商正致力於開發用於抗癌治療的學名藥注射劑。此外，用於抗癌治療的大量學名藥產品正在開發中，其中幾種學名藥計劃引入市場。

學名藥注射藥品合約製造市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

學名藥合約製造市場-競爭格局：

在學名藥合約製造市場的競爭領域，公司採用多方面的策略來確保其突出地位和生存能力。這些實體優先考慮成本效益，精心調整製造流程，以具有競爭力的價格提供高品質的學名藥注射藥物。品質和合規性仍然是不容談判的，堅定地致力於滿足 cGMP 等嚴格的監管標準，推動對尖端技術和現代化設施的投資。服務多樣化是一個關鍵追求，因為合約製造商擴大了其產品範圍，涵蓋各種注射劑形式，以滿足不同的客戶需求和市場需求。同時，對研發的高度重視推動創新，尋求製造技術、配方和藥物傳遞系統的進步，以在不斷發展的環境中保持領先地位。建立策略夥伴關係和聯盟，促進與尋求外包解決方案的製藥公司的長期合作，確保共同成長和穩定。此外，全球視野推動了擴張計劃，在不同地區建立製造中心，以滿足更廣泛的市場，同時遵守地區法規。總的來說，這些策略使這些公司能夠駕馭製藥業複雜的動態，推動學名藥注射藥品合約製造市場的競爭力和持續成長。

最近的發展：

2023 年 3 月，生物製藥合約製造商 PCI Pharma Services 披露，計劃投資 5,000 萬美元擴建其位於伊利諾伊州羅克福德的無菌注射劑工廠。

目錄

第 1 章：學名藥注射藥品合約製造市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按材料類型分類的通用注射藥品合約製造市場片段
    • 按應用分類的學名藥合約製造市場片段
    • 最終用戶的學名藥合約製造市場片段
    • 按國家/地區分類的學名藥合約製造市場片段
    • 按地區分類的學名藥合約製造市場片段
  • 競爭洞察

第 3 章：學名藥注射藥品合約製造主要市場趨勢

  • 學名藥合約製造市場促進因素
    • 市場促進因素的影響分析
  • 學名藥注射藥品合約製造市場限制
    • 市場限制影響分析
  • 學名藥注射劑合約製造市場機會
  • 學名藥合約製造市場未來趨勢

第 4 章：學名藥注射藥品合約製造業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：學名藥注射藥品合約製造市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：學名藥注射藥品合約製造市場格局

  • 2022 年學名藥注射藥品合約製造市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：學名藥注射藥品合約製造市場 - 按材料類型

  • 概述
    • 按材料類型分類的細分市場佔有率分析
    • 小分子
    • 大分子

第 8 章：學名藥注射藥品合約製造市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 腫瘤學
    • 免疫學
    • 抗糖尿病
    • 神經病學
    • 心血管
    • 呼吸系統
    • 其他

第 9 章：學名藥注射藥品合約製造市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 大型製藥公司
    • 中小型製藥公司
    • 學名藥公司
    • 其他

第 10 章：學名藥注射藥品合約製造市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美學名藥注射劑合約製造主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按材料類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲學名藥注射劑合約製造主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按材料類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區學名藥注射劑合約製造主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按材料類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲注射劑學名藥合約製造主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按材料類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲學名藥注射合約製造主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按材料類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 學名藥注射藥品合約製造業

  • 競爭儀表板
  • 公司簡介
    • Hikma Pharmaceuticals plc
    • Pfizer Inc.
    • Fresenius Kabi
    • Sandoz AG
    • Jubilant Pharma Limited
    • Baxter
    • PCI Pharma Services
    • Gland Pharma Limited (USA)
    • Dr. Reddy's Laboratories Ltd.
    • Grand River Aseptic Manufacturing
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2032

REPORT HIGHLIGHT

Generic Injectable Pharmaceutical Contract Manufacturing Market size was valued at USD 10,100 Million in 2022, expanding at a CAGR of 11.2% from 2023 to 2030.

Generic Injectable Pharmaceutical Contract Manufacturing involves specialized contract manufacturers producing non-brand name injectable medications (e.g., intravenous, intramuscular, or subcutaneous routes) for pharmaceutical companies. This sector thrives on intricate manufacturing demands, investments in R&D, technological advancements, patent expirations, and pandemic impacts. It caters to cell and gene therapies, personalized medicines, HPAPI, and ADC markets. With a growing demand for cost-effective injectable drugs and an ongoing need in global healthcare, stakeholders collaborate to ensure regulatory compliance, quality production, and accessibility to affordable medications. Key segments include large molecule drugs (e.g., biosimilars) and oncology-focused products, witnessing continuous growth and innovation in the pharmaceutical market.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Market Dynamics

Manufacturing demands of the pharmaceutical industry, heightened investments in pharmaceutical research and development to propel market demand

The expansion of this market primarily stems from the intricate manufacturing demands of the pharmaceutical industry, heightened investments in pharmaceutical research and development (R&D), a growing inclination towards advanced technologies, patent expirations, and the impact of the coronavirus pandemic. Moreover, the rising demand for cell and gene therapies, personalized medicines, as well as the surge in the High-potency Active Pharmaceutical Ingredients (HPAPI) and Antibody-drug Conjugates (ADC) markets, is anticipated to present significant opportunities for market participants. The continued increase in demand for cost-effective generic injectable drugs, coupled with the ongoing necessity for such medications within global healthcare systems, propels the growth of this market segment. Various stakeholders collaborate to meet regulatory standards, ensure quality production, and address healthcare needs for accessible and affordable injectable medications.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2023-2030)

Based on Material Type segmentation, large molecule was predicted to show maximum market share in the year 2022

Based on application segmentation, Oncology was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Generic Injectable Pharmaceutical Contract Manufacturing Market- Segmentation Analysis:

The Global Generic Injectable Pharmaceutical Contract Manufacturing Market is segmented on the basis of Material Type, Application, End User, and Region.

The market is divided into two categories based on Material Type: Small Molecule and large Molecule. Based on material type, the significant revenue share in 2022 was held by the large molecule segment. The substantial focus on customized treatments and precision medicine significantly contributes to the growth of the large molecule generic injectable drugs segment in the U.S. Furthermore, the rise in product launches, including biosimilars, notably supports segment expansion. For instance, in January 2023, Amgen introduced AMJEVITA, a biosimilar to Humira, in the U.S. It was the first generic version of Humira approved by the U.S. FDA, indicative of factors expected to bolster segment growth.

The market is divided into seven categories based on application: Oncology, Immunology, Antidiabetic. Neurology, Cardiovascular, Respiratory and Others. Based on application, the oncology segment secured the largest revenue share in 2022. This is attributed to the increasing launch of generic products tailored for cancer treatment. Numerous contract manufacturers are concentrating on developing generic injectables for anti-cancer therapy. Additionally, a considerable pipeline of generic products for anti-cancer therapies is in progress, with several generic drugs slated for introduction into the market.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Competitive Landscape:

In the competitive realm of the Generic Injectable Pharmaceutical Contract Manufacturing Market, companies employ multifaceted strategies to ensure their prominence and viability. These entities prioritize cost-effectiveness, meticulously fine-tuning manufacturing processes to deliver high-quality generic injectable medications at competitive prices. Quality and compliance remain non-negotiable, with a steadfast commitment to meeting stringent regulatory standards such as cGMP, driving investments in cutting-edge technologies and modern facilities. Diversification of services is a key pursuit, as contract manufacturers broaden their offerings to encompass various injectable formats, accommodating diverse client needs and market demands. Simultaneously, heavy emphasis on research and development fuels innovation, seeking advancements in manufacturing techniques, formulations, and drug delivery systems to stay ahead in the evolving landscape. Strategic partnerships and alliances are forged, fostering long-term collaborations with pharmaceutical firms seeking outsourcing solutions, ensuring mutual growth and stability. Moreover, a global outlook propels expansion initiatives, establishing manufacturing hubs in different regions to cater to a broader market while complying with regional regulations. Collectively, these strategies enable these companies to navigate the intricate dynamics of the pharmaceutical industry, driving competitiveness and sustained growth within the Generic Injectable Pharmaceutical Contract Manufacturing Market.

Recent Developments:

In March 2023, PCI Pharma Services, a biopharmaceutical contract manufacturer, disclosed plans to invest USD 50 million in expanding its sterile injectables facility situated in Rockford, Illinois.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Hikma Pharmaceuticals plc
  • Pfizer Inc.
  • Fresenius Kabi
  • Sandoz AG
  • Jubilant Pharma Limited
  • Baxter
  • PCI Pharma Services
  • Gland Pharma Limited (USA)
  • Dr. Reddy's Laboratories Ltd.
  • Grand River Aseptic Manufacturing
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY MATERIAL TYPE

  • Small Molecule
  • Large Molecule

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY APPLICATION

  • Oncology
  • Immunology
  • Antidiabetic
  • Neurology
  • Cardiovascular
  • Respiratory
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER

  • Big Pharmaceutical Companies
  • Small & Mid Sized Pharmaceutical Companies
  • Generic Pharmaceutical Companies
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Generic Injectable Pharmaceutical Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Material Type
    • 2.1.2. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Application
    • 2.1.3. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by End User
    • 2.1.4. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Country
    • 2.1.5. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Generic Injectable Pharmaceutical Contract Manufacturing Key Market Trends

  • 3.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Generic Injectable Pharmaceutical Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Generic Injectable Pharmaceutical Contract Manufacturing Market Opportunities
  • 3.4. Generic Injectable Pharmaceutical Contract Manufacturing Market Future Trends

4. Generic Injectable Pharmaceutical Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Generic Injectable Pharmaceutical Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Generic Injectable Pharmaceutical Contract Manufacturing Market Landscape

  • 6.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Generic Injectable Pharmaceutical Contract Manufacturing Market - By Material Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Material Type, 2022 & 2030 (%)
    • 7.1.2. Small Molecule
    • 7.1.3. Large Molecule

8. Generic Injectable Pharmaceutical Contract Manufacturing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Oncology
    • 8.1.3. Immunology
    • 8.1.4. Antidiabetic
    • 8.1.5. Neurology
    • 8.1.6. Cardiovascular
    • 8.1.7. Respiratory
    • 8.1.8. Others

9. Generic Injectable Pharmaceutical Contract Manufacturing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Big Pharmaceutical Companies
    • 9.1.3. Small & Mid Sized Pharmaceutical Companies
    • 9.1.4. Generic Pharmaceutical Companies
    • 9.1.5. Others

10. Generic Injectable Pharmaceutical Contract Manufacturing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Generic Injectable Pharmaceutical Contract Manufacturing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Hikma Pharmaceuticals plc
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Fresenius Kabi
    • 11.2.4. Sandoz AG
    • 11.2.5. Jubilant Pharma Limited
    • 11.2.6. Baxter
    • 11.2.7. PCI Pharma Services
    • 11.2.8. Gland Pharma Limited (USA)
    • 11.2.9. Dr. Reddy's Laboratories Ltd.
    • 11.2.10. Grand River Aseptic Manufacturing
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Material Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Material Type
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)